Overview

Tacrolimus as Secondary Intervention vs. Continuation of Cyclosporine in Renal Transplant Patients With Chronic Renal Allograft Failure (CRAF)

Status:
Completed

Trial end date:
2006-02-01

Target enrollment:

Participant gender:

Summary

The purpose of this study is to compare renal transplant recipients on cyclosporine maintenance therapy vs. those converted to tacrolimus-based immunosuppression with respect to renal outcomes.

Phase:

Phase 4

Details

Lead Sponsor:

Astellas Pharma Inc

Collaborator:

Astellas Pharma Canada, Inc.

Treatments:

Cyclosporine
Cyclosporins
Tacrolimus